Praxis Precisions Medicines Inc (PRAX) Event June 01, 2022, 20:37 UTC (99% Neutral) PRAXIS PRECISION MEDICINES, INC. (PRAX) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 2, 2025, 3:21 a.m. 📋 PRAXIS PRECISION MEDICINES, INC. (PRAX) - Regulatory Update Filing Date: 2022-06-01 Accepted: 2022-06-01 16:37:12 Event Type: Regulatory Update Event Details: Praxis Precisions Medicines Inc (PRAX) Announces Regulatory Update Praxis Precisions Medicines Inc (PRAX) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 🔬 Clinical Development Pipeline (PRAXIS PRECISION MEDICINES, INC.): Product Type Development Stage Therapeutic Area Source Placebo DRUG Phase PHASE3 Essential Tremor ClinicalTrials.gov 60 mg ulixacaltamide DRUG Phase PHASE3 Essential Tremor ClinicalTrials.gov 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Praxis Precisions Medicines IncCIK: 0001689548Ticker Symbol: PRAXPeriod End Date: 2022-05-26Document Type: 8-K
📋 PRAXIS PRECISION MEDICINES, INC. (PRAX) - Regulatory Update
Filing Date: 2022-06-01
Accepted: 2022-06-01 16:37:12
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (PRAXIS PRECISION MEDICINES, INC.):
💼 Business Developments:
Structured Data: